Shanwani A, Nor Azmi M, Amri Nil
Department of Surgery, Hospital Raja Perempuan Zainab II, Kota Bharu, Kelantan, Malaysia.
Dis Colon Rectum. 2010 Jan;53(1):39-42. doi: 10.1007/DCR.0b013e3181c160c4.
This study was designed to assess the total anal sphincter-saving technique of ligating the intersphincteric fistula tract for the treatment of fistula-in-ano.
We performed a prospective observational study of patients with fistula-in-ano treated with the ligation of the intersphincteric fistula tract technique from May 2007 through September 2008. All patients had fistulas arising from cryptoglandular infections. Recurrence rate, healing time, and morbidities related to the procedure were determined with a standard follow-up protocol.
Forty-five patients with transsphincteric (n = 33) or complex (n = 12) fistulas were included in the study. Five patients (11.1%) had recurrent fistula-in-ano after prior surgery using other recognized treatment procedures. The median age was 41.5 (range, 27-56) years; median follow-up, 9 (range, 2-16) months. Primary healing was achieved in 37 patients (82.2%), with a median healing time of 7 (range, 4-10) weeks. Eight patients (17.7%) had recurrence of fistula between 3 and 8 months after the operation. No clinically significant morbidity was noted in any of the 45 patients.
The ligation of the intersphincteric fistula tract technique for fistula-in-ano surgery, which aims at total anal sphincter preservation, appears to be both safe and easy to perform, with encouraging early outcomes.
本研究旨在评估结扎括约肌间瘘管的全肛门括约肌保留技术治疗肛瘘的效果。
我们对2007年5月至2008年9月期间采用结扎括约肌间瘘管技术治疗的肛瘘患者进行了前瞻性观察研究。所有患者的肛瘘均由隐窝腺感染引起。通过标准的随访方案确定复发率、愈合时间以及与手术相关的并发症。
45例经括约肌型(n = 33)或复杂型(n = 12)肛瘘患者纳入研究。5例患者(11.1%)在先前使用其他公认治疗方法手术后出现复发性肛瘘。中位年龄为41.5岁(范围27 - 56岁);中位随访时间为9个月(范围2 - 16个月)。37例患者(82.2%)实现一期愈合,中位愈合时间为7周(范围4 - 10周)。8例患者(17.7%)在术后3至8个月出现肛瘘复发。45例患者中均未发现具有临床意义的并发症。
旨在保留全肛门括约肌的结扎括约肌间瘘管技术用于肛瘘手术,似乎既安全又易于操作,早期效果令人鼓舞。